ID 150 (Ibandronate Sodium 150 mg)
Pill with imprint ID 150 is Yellow, Capsule-shape and has been identified as Ibandronate Sodium 150 mg. It is supplied by Alvogen Inc.
Ibandronate is used in the treatment of osteoporosis; prevention of osteoporosis and belongs to the drug class bisphosphonates. Risk cannot be ruled out during pregnancy. Ibandronate 150 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ID 150
Ibandronate Sodium
- Imprint:
- ID 150
- Strength:
- 150 mg
- Color:
- Yellow
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Bisphosphonates
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Alvogen Inc
- National Drug Code (NDC):
- 47781-0103
More about ibandronate
- Ibandronate Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 45 Reviews
- Drug class: bisphosphonates
Consumer resources
- Ibandronate oral/injection
- Ibandronate Injection
- Ibandronate Tablets
- Ibandronate Intravenous (Advanced Reading)
- Ibandronate Oral, Injection (Advanced Reading)
Other brands: Boniva
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
